Clinical Trial Update: Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pneumatic displacement of subretinal hemorrhage using perfluorocarbon gases; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subretinal Hemorrhage and Exudative Maculopathy

Drugs mentioned

• Perfluorocarbon gases

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Subretinal Hemorrhage and Exudative Maculopathy | Phase 2 | Status: UNKNOWN